Covid, AstraZeneca director: pandemic recovery extremely unlikely
Professor Andrew Pollard, director of the Oxford Vaccine Group that developed the AstraZeneca vaccine, expressed cautious optimism that existing vaccines could be effective in preventing serious diseases due to the Omicron variant of the coronavirus. He said most of the mutations appear to be similar to those of other variants. “This tells us that despite those mutations existing in other variants, the vaccines continued to prevent serious disease as we went through the Alpha, Beta, Gamma and Delta variants,” he told BBC radio.
“At least from a speculative point of view, we have some optimism that the vaccine should still work against a new variant for a serious disease, but in reality we have to wait several weeks for confirmation.” Pollard added that it is “extremely unlikely that there will be a resurgence of the pandemic like the one we saw last year in a vaccinated population.”